I'm sure they did, but they did not stratify by agegroup (adult/child) during randomisation. FDA did do post hoc analysis by agegroup, but not statistically significant (underpowered for subanalysis)
pxs target $1.15- credit suisse, page-10
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
-0.003(6.67%) |
Mkt cap ! $57.67M | |||
| Open | High | Low | Value | Volume |
| 4.5¢ | 4.5¢ | 4.2¢ | $57.82K | 1.360M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 368290 | 4.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 133896 | 4 |
View Market Depth
| Last trade - 15.43pm 08/10/2024 (20 minute delay) ? |
| SNT (ASX) Chart |